This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Simon, C. Articles by Boyd, D. Search for Related Content PubMed PubMed Citation Articles by Simon, C. Articles by Boyd, D.

Inhibition of the p38 Mitogen-activated Protein Kinase by SB 203580 Blocks PMA-induced M_r 92,000 Type IV Collagenase Secretion and in Vitro Invasion¹

Departments of Head and Neck Surgery and Tumor Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

Although the p38 mitogen-activated protein kinase (MAPK) has been implicated in signal transduction events, its role in regulating the M_r 92,000 type IV collagenase matrix metalloprotease-9 (MMP-9) and in vitro invasiveness in cancer has not yet been determined. We made the surprising observation that, in a human squamous cell carcinoma cell line (UM-SCC-1), phorbol ester-enhanced MMP-9 secretion and in vitro invasiveness were associated with a strong activation of the p38 MAPK and its downstream target, MAPK-activated protein kinase-2. To determine the role of p38 activation in these events, we investigated the effect of SB 203580, a novel specific p38 inhibitor, on protease expression and in vitro invasion of these cells. We found that inhibition of p38 by SB 203580 resulted in the almost complete reduction of phorbol myristate acetate-induced MMP-9 secretion but not of urokinase-type plasminogen activator secretion. In contrast, the activation of a transiently transfected wild-type MMP-9 promoter by MEKK-1, a specific c-Jun NH₂-terminal kinase activator, was only marginally inhibited by the compound, arguing for the specificity of SB 203580. Moreover, phorbol myristate acetate-enhanced in vitro invasion was completely blocked by SB 203580, whereas p38 inhibition had little effect on growth. These findings suggest that activation of p38 may contribute to a more invasive phenotype in vitro, possibly via the expression of MMP-9, and that targeting of p38 using SB 203580 may provide a novel means of controlling invasion of cancers in which this MAPK is activated.

¹ This work was supported by NIH Grants ROI DE10845, ROI CA58311, and P50 DE11906 (to D. B.) and Deutsche Forschungsgemeinschaft Fellowship Si 634/1-1 (to C. S.).

² To whom requests for reprints should be addressed, at Department of Tumor Biology, Box 108, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030.

Received 1/ 6/98. Accepted 1/26/98.

This article has been cited by other articles:

				H. Song, Y. Li, J. Lee, A. L. Schwartz, and G. Bu Low-Density Lipoprotein Receptor-Related Protein 1 Promotes Cancer Cell Migration and Invasion by Inducing the Expression of Matrix Metalloproteinases 2 and 9 Cancer Res., February 1, 2009; 69(3): 879 - 886. [Abstract] [Full Text] [PDF]

				T. R. Johnson, L. Khandrika, B. Kumar, S. Venezia, S. Koul, R. Chandhoke, P. Maroni, R. Donohue, R. B. Meacham, and H. K. Koul Focal Adhesion Kinase Controls Aggressive Phenotype of Androgen-Independent Prostate Cancer Mol. Cancer Res., October 1, 2008; 6(10): 1639 - 1648. [Abstract] [Full Text] [PDF]

				C.-J. Weng, C.-F. Chau, Y.-S. Hsieh, S.-F. Yang, and G.-C. Yen Lucidenic acid inhibits PMA-induced invasion of human hepatoma cells through inactivating MAPK/ERK signal transduction pathway and reducing binding activities of NF-{kappa}B and AP-1 Carcinogenesis, January 1, 2008; 29(1): 147 - 156. [Abstract] [Full Text] [PDF]

				T. Okawa, C. Z. Michaylira, J. Kalabis, D. B. Stairs, H. Nakagawa, C. Andl, C. N. Johnstone, A. J. Klein-Szanto, W. S. El-Deiry, E. Cukierman, et al. The functional interplay between EGFR overexpression, hTERT activation, and p53 mutation in esophageal epithelial cells with activation of stromal fibroblasts induces tumor development, invasion, and differentiation Genes & Dev., November 1, 2007; 21(21): 2788 - 2803. [Abstract] [Full Text] [PDF]

				M. N. Younes, Y. W. Park, Y. D. Yazici, M. Gu, A. A. Santillan, X. Nong, S. Kim, S. A. Jasser, A. K. El-Naggar, and J. N. Myers Concomitant inhibition of epidermal growth factor and vascular endothelial growth factor receptor tyrosine kinases reduces growth and metastasis of human salivary adenoid cystic carcinoma in an orthotopic nude mouse model. Mol. Cancer Ther., November 1, 2006; 5(11): 2696 - 2705. [Abstract] [Full Text] [PDF]

				R. R. Nair, J. Solway, and D. D. Boyd Expression Cloning Identifies Transgelin (SM22) as a Novel Repressor of 92-kDa Type IV Collagenase (MMP-9) Expression J. Biol. Chem., September 8, 2006; 281(36): 26424 - 26436. [Abstract] [Full Text] [PDF]

				A. Behren, C. Simon, R. M. Schwab, E. Loetzsch, S. Brodbeck, E. Huber, F. Stubenrauch, H. P. Zenner, and T. Iftner Papillomavirus E2 Protein Induces Expression of the Matrix Metalloproteinase-9 via the Extracellular Signal-Regulated Kinase/Activator Protein-1 Signaling Pathway Cancer Res., December 15, 2005; 65(24): 11613 - 11621. [Abstract] [Full Text] [PDF]

				S. Hong, K.-K. Park, J. Magae, K. Ando, T.-S. Lee, T. K. Kwon, J.-Y. Kwak, C.-H. Kim, and Y.-C. Chang Ascochlorin Inhibits Matrix Metalloproteinase-9 Expression by Suppressing Activator Protein-1-mediated Gene Expression through the ERK1/2 Signaling Pathway: INHIBITORY EFFECTS OF ASCOCHLORIN ON THE INVASION OF RENAL CARCINOMA CELLS J. Biol. Chem., July 1, 2005; 280(26): 25202 - 25209. [Abstract] [Full Text] [PDF]

				S. S. Lakka, C. S. Gondi, D. H. Dinh, W. C. Olivero, M. Gujrati, V. H. Rao, C. Sioka, and J. S. Rao Specific Interference of Urokinase-type Plasminogen Activator Receptor and Matrix Metalloproteinase-9 Gene Expression Induced by Double-stranded RNA Results in Decreased Invasion, Tumor Growth, and Angiogenesis in Gliomas J. Biol. Chem., June 10, 2005; 280(23): 21882 - 21892. [Abstract] [Full Text] [PDF]

				S. Zhuang, Y. Yan, J. Han, and R. G. Schnellmann p38 Kinase-mediated Transactivation of the Epidermal Growth Factor Receptor Is Required for Dedifferentiation of Renal Epithelial Cells after Oxidant Injury J. Biol. Chem., June 3, 2005; 280(22): 21036 - 21042. [Abstract] [Full Text] [PDF]

				Y. Kato, C. A. Lambert, A. C. Colige, P. Mineur, A. Noel, F. Frankenne, J.-M. Foidart, M. Baba, R.-I. Hata, K. Miyazaki, et al. Acidic Extracellular pH Induces Matrix Metalloproteinase-9 Expression in Mouse Metastatic Melanoma Cells through the Phospholipase D-Mitogen-activated Protein Kinase Signaling J. Biol. Chem., March 25, 2005; 280(12): 10938 - 10944. [Abstract] [Full Text] [PDF]

				H.-S. Kim, L. Luo, S. C. Pflugfelder, and D.-Q. Li Doxycycline Inhibits TGF-{beta}1-Induced MMP-9 via Smad and MAPK Pathways in Human Corneal Epithelial Cells Invest. Ophthalmol. Vis. Sci., March 1, 2005; 46(3): 840 - 848. [Abstract] [Full Text] [PDF]

				C.-H. Woo, J.-H. Lim, and J.-H. Kim Lipopolysaccharide Induces Matrix Metalloproteinase-9 Expression via a Mitochondrial Reactive Oxygen Species-p38 Kinase-Activator Protein-1 Pathway in Raw 264.7 Cells J. Immunol., December 1, 2004; 173(11): 6973 - 6980. [Abstract] [Full Text] [PDF]

				Z. Lin, D. K. Crockett, S. D. Jenson, M. S. Lim, and K. S. J. Elenitoba-Johnson Quantitative Proteomic and Transcriptional Analysis of the Response to the p38 Mitogen-activated Protein Kinase Inhibitor SB203580 in Transformed Follicular Lymphoma Cells Mol. Cell. Proteomics, August 1, 2004; 3(8): 820 - 833. [Abstract] [Full Text] [PDF]

				P. Kunapuli, C. S. Kasyapa, L. Hawthorn, and J. K. Cowell LGI1, a Putative Tumor Metastasis Suppressor Gene, Controls in Vitro Invasiveness and Expression of Matrix Metalloproteinases in Glioma Cells through the ERK1/2 Pathway J. Biol. Chem., May 28, 2004; 279(22): 23151 - 23157. [Abstract] [Full Text] [PDF]

				S. Shetty and S. Idell Urokinase Receptor mRNA Stability Involves Tyrosine Phosphorylation in Lung Epithelial Cells Am. J. Respir. Cell Mol. Biol., January 1, 2004; 30(1): 69 - 75. [Abstract] [Full Text] [PDF]

				A. Huwiler, E.-S. Akool, A. Aschrafi, F. M. A. Hamada, J. Pfeilschifter, and W. Eberhardt ATP Potentiates Interleukin-1{beta}-induced MMP-9 Expression in Mesangial Cells via Recruitment of the ELAV Protein HuR J. Biol. Chem., December 19, 2003; 278(51): 51758 - 51769. [Abstract] [Full Text] [PDF]

				M.-S. Kim, E.-J. Lee, H.-R. C. Kim, and A. Moon p38 Kinase Is a Key Signaling Molecule for H-Ras-induced Cell Motility and Invasive Phenotype in Human Breast Epithelial Cells Cancer Res., September 1, 2003; 63(17): 5454 - 5461. [Abstract] [Full Text] [PDF]

				W.-C. Lai, M. Zhou, U. Shankavaram, G. Peng, and L. M. Wahl Differential Regulation of Lipopolysaccharide-Induced Monocyte Matrix Metalloproteinase (MMP)-1 and MMP-9 by p38 and Extracellular Signal-Regulated Kinase 1/2 Mitogen-Activated Protein Kinases J. Immunol., June 15, 2003; 170(12): 6244 - 6249. [Abstract] [Full Text] [PDF]

				N. Chandrasekar, S. Mohanam, S. S. Lakka, D. H. Dinh, W. C. Olivero, M. Gujrati, and Jasti. S. Rao Glial Cell-induced Endothelial Morphogenesis Is Inhibited by Interfering with Extracellular Signal-regulated Kinase Signaling Clin. Cancer Res., June 1, 2003; 9(6): 2342 - 2349. [Abstract] [Full Text] [PDF]

				C. Yu, M. Rahmani, Y. Dai, D. Conrad, G. Krystal, P. Dent, and S. Grant The Lethal Effects of Pharmacological Cyclin-dependent Kinase Inhibitors in Human Leukemia Cells Proceed through a Phosphatidylinositol 3-Kinase/Akt-dependent Process Cancer Res., April 15, 2003; 63(8): 1822 - 1833. [Abstract] [Full Text] [PDF]

				H. G. Munshi, Y. I. Wu, E. V. Ariztia, and M. S. Stack Calcium Regulation of Matrix Metalloproteinase-mediated Migration in Oral Squamous Cell Carcinoma Cells J. Biol. Chem., October 25, 2002; 277(44): 41480 - 41488. [Abstract] [Full Text] [PDF]

				G. Choe, J. K. Park, L. Jouben-Steele, T. J. Kremen, L. M. Liau, H. V. Vinters, T. F. Cloughesy, and P. S. Mischel Active Matrix Metalloproteinase 9 Expression Is Associated with Primary Glioblastoma Subtype Clin. Cancer Res., September 1, 2002; 8(9): 2894 - 2901. [Abstract] [Full Text] [PDF]

				N. Reunanen, S.-P. Li, M. Ahonen, M. Foschi, J. Han, and V.-M. Kahari Activation of p38alpha MAPK Enhances Collagenase-1 (Matrix Metalloproteinase (MMP)-1) and Stromelysin-1 (MMP-3) Expression by mRNA Stabilization J. Biol. Chem., August 23, 2002; 277(35): 32360 - 32368. [Abstract] [Full Text] [PDF]

				C. A. Rivera-Marrero, W. Schuyler, S. Roser, J. D. Ritzenthaler, S. A. Newburn, and J. Roman M. tuberculosis induction of matrix metalloproteinase-9: the role of mannose and receptor-mediated mechanisms Am J Physiol Lung Cell Mol Physiol, March 1, 2002; 282(3): L546 - L555. [Abstract] [Full Text] [PDF]

				M. O. Hannigan, L. Zhan, Y. Ai, A. Kotlyarov, M. Gaestel, and C.-K. Huang Abnormal Migration Phenotype of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2-/- Neutrophils in Zigmond Chambers Containing Formyl-Methionyl-Leucyl-Phenylalanine Gradients J. Immunol., October 1, 2001; 167(7): 3953 - 3961. [Abstract] [Full Text] [PDF]

				S. M. Ellerbroek, J. M. Halbleib, M. Benavidez, J. K. Warmka, E. V. Wattenberg, M. S. Stack, and L. G. Hudson Phosphatidylinositol 3-Kinase Activity in Epidermal Growth Factor-stimulated Matrix Metalloproteinase-9 Production and Cell Surface Association Cancer Res., March 1, 2001; 61(5): 1855 - 1861. [Abstract] [Full Text]

				M. Hidalgo and S. G. Eckhardt Development of Matrix Metalloproteinase Inhibitors in Cancer Therapy J Natl Cancer Inst, February 7, 2001; 93(3): 178 - 193. [Abstract] [Full Text] [PDF]

				A. Cho, J. Graves, and M. A. Reidy Mitogen-Activated Protein Kinases Mediate Matrix Metalloproteinase-9 Expression in Vascular Smooth Muscle Cells Arterioscler Thromb Vasc Biol, December 1, 2000; 20(12): 2527 - 2532. [Abstract] [Full Text] [PDF]

				W. Eberhardt, A. Huwiler, K.-F. Beck, S. Walpen, and J. Pfeilschifter Amplification of IL-1{beta}-Induced Matrix Metalloproteinase-9 Expression by Superoxide in Rat Glomerular Mesangial Cells Is Mediated by Increased Activities of NF-{kappa}B and Activating Protein-1 and Involves Activation of the Mitogen-Activated Protein Kinase Pathways J. Immunol., November 15, 2000; 165(10): 5788 - 5797. [Abstract] [Full Text] [PDF]

				D. C. Underwood, R. R. Osborn, S. Bochnowicz, E. F. Webb, D. J. Rieman, J. C. Lee, A. M. Romanic, J. L. Adams, D. W. P. Hay, and D. E. Griswold SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung Am J Physiol Lung Cell Mol Physiol, November 1, 2000; 279(5): L895 - L902. [Abstract] [Full Text] [PDF]

				S.-M. Chuang, G.-Y. Liou, and J.-L. Yang Activation of JNK, p38 and ERK mitogen-activated protein kinases by chromium(VI) is mediated through oxidative stress but does not affect cytotoxicity Carcinogenesis, August 1, 2000; 21(8): 1491 - 1500. [Abstract] [Full Text] [PDF]

				S.-M. Chuang, I-C. Wang, and J.-L. Yang Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium Carcinogenesis, July 1, 2000; 21(7): 1423 - 1432. [Abstract] [Full Text] [PDF]

				L. J. McCawley, S. Li, M. Benavidez, J. Halbleib, E. V. Wattenberg, and L. G. Hudson Elevation of Intracellular cAMP Inhibits Growth Factor-Mediated Matrix Metalloproteinase-9 Induction and Keratinocyte Migration Mol. Pharmacol., July 1, 2000; 58(1): 145 - 151. [Abstract] [Full Text]

				S. Huang, L. New, Z. Pan, J. Han, and G. R. Nemerow Urokinase Plasminogen Activator/Urokinase-specific Surface Receptor Expression and Matrix Invasion by Breast Cancer Cells Requires Constitutive p38alpha Mitogen-activated Protein Kinase Activity J. Biol. Chem., April 14, 2000; 275(16): 12266 - 12272. [Abstract] [Full Text] [PDF]

				C. Li, Y. Hu, G. Sturm, G. Wick, and Q. Xu Ras/Rac-Dependent Activation of p38 Mitogen-Activated Protein Kinases in Smooth Muscle Cells Stimulated by Cyclic Strain Stress Arterioscler Thromb Vasc Biol, March 1, 2000; 20 (3): e1 - e9. [Abstract] [Full Text] [PDF]

				E Genersch, K Hayess, Y Neuenfeld, and H Haller Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: involvement of Ras-dependent and -independent pathways J. Cell Sci., January 12, 2000; 113(23): 4319 - 4330. [Abstract] [PDF]

				N Johansson, R Ala-aho, V Uitto, R Grenman, N. Fusenig, C Lopez-Otin, and V. Kahari Expression of collagenase-3 (MMP-13) and collagenase-1 (MMP-1) by transformed keratinocytes is dependent on the activity of p38 mitogen-activated protein kinase J. Cell Sci., January 1, 2000; 113(2): 227 - 235. [Abstract] [PDF]

				Z. Han, D. L. Boyle, K. R. Aupperle, B. Bennett, A. M. Manning, and G. S. Firestein Jun N-Terminal Kinase in Rheumatoid Arthritis J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 124 - 130. [Abstract] [Full Text]

				L. Montero and Y. Nagamine Regulation by p38 Mitogen-activated Protein Kinase of Adenylate- and Uridylate-Rich Element-mediated Urokinase-Type Plasminogen Activator (uPA) Messenger RNA Stability and uPA-dependent in Vitro Cell Invasion Cancer Res., October 1, 1999; 59(20): 5286 - 5293. [Abstract] [Full Text] [PDF]

				A. Suzuki, G. Palmer, J.-P. Bonjour, and J. Caverzasio Regulation of Alkaline Phosphatase Activity by p38 MAP Kinase in Response to Activation of Gi Protein-Coupled Receptors by Epinephrine in Osteoblast-Like Cells Endocrinology, July 1, 1999; 140(7): 3177 - 3182. [Abstract] [Full Text]

				J. WESTERMARCK and V.-M. KÄHÄRI Regulation of matrix metalloproteinase expression in tumor invasion FASEB J, May 1, 1999; 13(8): 781 - 792. [Abstract] [Full Text]

				L. J. McCawley, S. Li, E. V. Wattenberg, and L. G. Hudson Sustained Activation of the Mitogen-activated Protein Kinase Pathway. A MECHANISM UNDERLYING RECEPTOR TYROSINE KINASE SPECIFICITY FOR MATRIX METALLOPROTEINASE-9 INDUCTION AND CELL MIGRATION J. Biol. Chem., February 12, 1999; 274(7): 4347 - 4353. [Abstract] [Full Text] [PDF]

				N. Reunanen, M. Foschi, J. Han, and V.-M. Kahari Activation of Extracellular Signal-regulated Kinase 1/2 Inhibits Type I Collagen Expression by Human Skin Fibroblasts J. Biol. Chem., October 27, 2000; 275(44): 34634 - 34639. [Abstract] [Full Text] [PDF]

				S.-O. Yoon, M.-M. Kim, and A.-S. Chung Inhibitory Effect of Selenite on Invasion of HT1080 Tumor Cells J. Biol. Chem., June 1, 2001; 276(23): 20085 - 20092. [Abstract] [Full Text] [PDF]